Teva Pharmaceuticals Receive Warning Letter from FDA – Parker Waichman LLP
FDA warning letter says Teva China plant has more work to do on API issues | Fierce Pharma
ARS Pharma Shares Fall as FDA Declines to Approve Epinephrine Nasal Spray Neffy - WSJ
Teva, MedinCell receive FDA approval for Uzedy for schizophrenia
Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval for Migraine Therapy - Warrior Trading News
FDA warns eye drops may cause infection. Here's a list of 27 products to which the alert applies. - CBS News
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Celltrion FDA warning causes headache for Teva's biologics ambition
FDA Issues Warning About Fake Adderall | Fox 8 Cleveland WJW
FDA warns fake Adderall ADD medication being sold online
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
The Latest Breaking News from Teva Pharmaceutical Industries Ltd – inkl news
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Teva confirms US FDA warning letter for Hangzhou, China API plant
TEVA Stock Pops 4% as Teva Receives FDA Approval | InvestorPlace
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
FDA warns of Adderall shortage after Teva manufacturing delay - YouTube
FDA cites 'significant' sterility concern at Teva injectables plant | Fierce Pharma
FDA Nod to New MS Drug Spells Trouble for Teva - Haaretz Com - Haaretz.com
Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens | Fierce Pharma
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
Teva recalls one lot of IDArubicin Hydrochloride Injection USP
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
FDA rejects Teva/Celltrion biosimilars | pharmaphorum
Warfarin Sodium by Teva Pharmaceuticals USA, Inc. WARFARIN SODIUM tablet
Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA) | FDA
